- Novartis Healthcare Philippines and AC Health have renewed their Integrated Cardiovascular and Cancer Care partnership to expand access to innovative medicines for breast cancer, heart failure, and high cholesterol, as well as to sustain patient-centered programs and empower the patient community.
Novartis Healthcare Philippines and AC Health announced the renewal of their Integrated Cardiovascular and Cancer Care partnership, reaffirming their shared commitment to broaden access to innovative therapies in breast cancer, heart failure, and high cholesterol, and to further empower patient communities across the country.
Building on the collaboration launched in May 2024, the renewed partnership will sustain and scale patient-centered initiatives, enhance healthcare professional engagement, and strengthen value-added services designed to improve adherence and outcomes. The initiative is anchored on co-created healthcare solutions that help get the right treatment to the right patient at the right time.
“Renewing our partnership with AC Health strengthens our shared commitment to reimagining medicine and delivering what matters to patients,” said Hyeyoon Park, Country President, Novartis Healthcare Philippines. “Inspired by patients and driven by science, we will sustain and scale programs that raise awareness, empower healthcare professionals, ensure appropriate product availability, and expand access to innovative treatments—so more Filipinos can achieve better health outcomes.”
"Our continued partnership with Novartis allows us to make essential and innovative medicines more accessible to our patients and customers across our network. By working together, we’re able to translate collaborations into real-world benefits — bringing affordable, high-quality treatment closer to the communities we serve." said Mr. Paolo Borromeo, President & CEO, AC Health.
The partnership will expand access to innovative medicines by co-creating solutions that improve outcomes, including patient awareness on breast cancer, heart failure, and high cholesterol; provider development; and value-added services that reduce barriers to care and support treatment adherence.
Through these efforts, Novartis and AC Health will advance integrated, evidence-based care pathways, foster collaboration across providers, and help more patients achieve better health outcomes.
About AC Health
Established in 2015, AC Health has rapidly grown into one of the country’s most dynamic and integrated healthcare networks, driven by its vision to transform health for every Filipino.
AC Health operates across two core pillars—provider and pharma—creating a seamless healthcare ecosystem that addresses the full continuum of care. Its portfolio includes Healthway Medical Network, a network of multi-specialty clinics, ambulatory centres, and full-service hospitals; Generika Drugstore, the pioneer in generic retail pharmacies; IE Medica and MedEthix, a major pharmaceutical importer and distributor; and St. Joseph Drug, a leading retail pharmacy in North and Central Luzon.
Through its provider and pharma pillars, AC Health creates a seamless and integrated healthcare ecosystem for the Filipino patient. Visit our website at https://www.achealth.com.ph and follow us on LinkedIn to learn more about the company.
For information:
Rafa Abaya
Email: [email protected]
About Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.